Nifty
Sensex
:
:
24967.75
81635.91
97.65 (0.39%)
329.06 (0.40%)

Pharmaceuticals & Drugs

Rating :
49/99

BSE: 506919 | NSE: Not Listed

146.15
25-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  149
  •  149.95
  •  145
  •  149.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  825
  •  120991
  •  149.95
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 86.23
  • 9.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 88.97
  • N/A
  • 1.20

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.27%
  • 2.28%
  • 31.01%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.51
  • 11.96
  • 6.04

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 0.66
  • 20.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.22
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.28
  • 1.28
  • 1.18

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.98
  • 12.98
  • 15.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
35.00
29.59
18.28%
33.90
27.81
21.90%
27.69
26.51
4.45%
29.57
25.07
17.95%
Expenses
31.99
27.78
15.15%
30.82
26.95
14.36%
26.38
26.31
0.27%
27.38
24.87
10.09%
EBITDA
3.01
1.81
66.30%
3.08
0.86
258.14%
1.31
0.20
555.00%
2.19
0.20
995.00%
EBIDTM
8.61%
6.12%
9.10%
3.10%
4.72%
0.76%
7.40%
0.80%
Other Income
0.27
0.38
-28.95%
0.12
0.43
-72.09%
0.88
0.37
137.84%
10.51
0.41
2,463.41%
Interest
0.18
0.49
-63.27%
0.18
0.52
-65.38%
0.19
0.53
-64.15%
0.43
0.49
-12.24%
Depreciation
1.12
1.28
-12.50%
0.90
1.15
-21.74%
1.31
1.16
12.93%
1.29
1.13
14.16%
PBT
1.98
-0.47
-
2.11
-0.38
-
0.68
-1.11
-
11.09
-1.02
-
Tax
0.69
0.23
200.00%
0.53
0.58
-8.62%
0.41
-0.06
-
1.33
0.11
1,109.09%
PAT
1.28
-0.70
-
1.58
-0.96
-
0.27
-1.06
-
9.76
-1.13
-
PATM
3.67%
-2.38%
4.67%
-3.46%
0.98%
-3.99%
33.01%
-4.49%
EPS
0.74
-1.67
-
-0.08
-2.18
-
-0.50
-2.62
-
14.94
-2.27
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
126.16
120.75
104.39
101.28
127.20
68.64
Net Sales Growth
15.76%
15.67%
3.07%
-20.38%
85.31%
 
Cost Of Goods Sold
58.56
52.21
51.94
39.07
50.20
27.59
Gross Profit
67.60
68.54
52.45
62.20
77.00
41.06
GP Margin
53.58%
56.76%
50.24%
61.41%
60.53%
59.82%
Total Expenditure
116.57
112.36
103.27
97.96
108.36
60.52
Power & Fuel Cost
-
10.88
11.32
12.70
8.78
5.55
% Of Sales
-
9.01%
10.84%
12.54%
6.90%
8.09%
Employee Cost
-
14.05
13.94
11.73
12.51
8.71
% Of Sales
-
11.64%
13.35%
11.58%
9.83%
12.69%
Manufacturing Exp.
-
28.70
19.14
28.56
29.60
12.68
% Of Sales
-
23.77%
18.34%
28.20%
23.27%
18.47%
General & Admin Exp.
-
3.46
3.17
2.88
2.77
2.20
% Of Sales
-
2.87%
3.04%
2.84%
2.18%
3.21%
Selling & Distn. Exp.
-
1.97
2.95
2.01
3.70
2.45
% Of Sales
-
1.63%
2.83%
1.98%
2.91%
3.57%
Miscellaneous Exp.
-
1.10
0.82
0.98
0.81
1.35
% Of Sales
-
0.91%
0.79%
0.97%
0.64%
1.97%
EBITDA
9.59
8.39
1.12
3.32
18.84
8.12
EBITDA Margin
7.60%
6.95%
1.07%
3.28%
14.81%
11.83%
Other Income
11.78
11.89
1.53
2.28
2.60
0.96
Interest
0.98
1.29
2.02
2.20
1.74
1.76
Depreciation
4.62
4.79
4.54
4.24
4.02
4.61
PBT
15.86
14.20
-3.92
-0.84
15.68
2.70
Tax
2.96
2.50
0.89
1.35
3.97
1.36
Tax Rate
18.66%
18.64%
-22.70%
-160.71%
25.30%
50.37%
PAT
12.89
7.49
-6.26
-4.75
4.98
-0.33
PAT before Minority Interest
8.90
10.91
-4.81
-2.19
11.72
1.35
Minority Interest
-3.99
-3.42
-1.45
-2.56
-6.74
-1.68
PAT Margin
10.22%
6.20%
-6.00%
-4.69%
3.92%
-0.48%
PAT Growth
434.81%
-
-
-
-
 
EPS
21.85
12.69
-10.61
-8.05
8.44
-0.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
70.51
63.05
69.20
59.58
54.13
Share Capital
5.90
5.90
5.90
4.92
4.92
Total Reserves
64.61
57.15
63.30
54.66
49.21
Non-Current Liabilities
11.56
19.75
15.08
13.23
16.50
Secured Loans
2.06
3.08
2.32
2.69
5.53
Unsecured Loans
0.00
6.00
2.00
0.00
0.00
Long Term Provisions
0.27
0.25
0.27
0.43
0.38
Current Liabilities
21.20
37.17
27.54
33.01
33.12
Trade Payables
11.70
16.70
10.14
5.46
14.53
Other Current Liabilities
7.88
11.93
10.99
13.79
8.94
Short Term Borrowings
0.30
7.19
4.55
11.67
6.32
Short Term Provisions
1.33
1.34
1.85
2.09
3.34
Total Liabilities
147.96
161.26
152.29
144.33
136.19
Net Block
74.15
86.57
84.52
68.30
71.39
Gross Block
119.35
135.94
129.77
109.97
81.94
Accumulated Depreciation
45.20
49.38
45.25
41.67
10.55
Non Current Assets
79.68
91.45
89.04
81.42
75.15
Capital Work in Progress
0.59
0.32
0.49
9.38
0.16
Non Current Investment
0.14
0.12
0.08
0.22
1.21
Long Term Loans & Adv.
4.68
4.39
3.91
2.99
1.82
Other Non Current Assets
0.11
0.06
0.05
0.53
0.56
Current Assets
68.27
69.80
63.25
62.91
61.04
Current Investments
0.00
2.81
0.00
0.00
0.75
Inventories
34.04
33.80
31.32
23.84
27.47
Sundry Debtors
27.63
19.89
19.87
13.55
16.61
Cash & Bank
0.65
2.23
4.37
8.67
6.22
Other Current Assets
5.96
1.02
0.88
3.84
9.99
Short Term Loans & Adv.
4.70
10.04
6.81
13.00
1.40
Net Current Assets
47.07
32.63
35.71
29.90
27.92
Total Assets
147.95
161.25
152.29
144.33
136.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-4.08
0.84
-8.62
18.50
0.00
PBT
13.41
-3.92
-0.84
15.69
0.00
Adjustment
-3.89
5.79
5.65
5.21
0.00
Changes in Working Capital
-11.20
0.74
-10.96
3.23
0.00
Cash after chg. in Working capital
-1.68
2.62
-6.15
24.13
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.40
-1.78
-2.47
-5.63
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
19.75
-6.89
1.25
-21.79
0.00
Net Fixed Assets
10.42
-1.94
-3.46
-9.83
Net Investments
-0.03
-0.04
0.03
1.11
Others
9.36
-4.91
4.68
-13.07
Cash from Financing Activity
-15.84
5.74
5.78
0.33
0.00
Net Cash Inflow / Outflow
-0.17
-0.31
-1.59
-2.96
0.00
Opening Cash & Equivalents
0.41
0.72
2.31
5.27
0.00
Closing Cash & Equivalent
0.24
0.41
0.72
2.31
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
119.49
106.85
117.28
121.17
105.62
ROA
7.06%
-3.07%
-1.48%
8.35%
0.99%
ROE
16.33%
-7.28%
-3.40%
20.61%
2.49%
ROCE
19.01%
-2.36%
1.72%
24.00%
6.53%
Fixed Asset Turnover
0.95
0.79
0.84
1.33
0.84
Receivable days
71.83
69.51
60.23
43.28
88.31
Inventory Days
102.53
113.86
99.41
73.62
146.06
Payable days
99.28
94.32
72.86
72.68
192.25
Cash Conversion Cycle
75.08
89.06
86.77
44.22
42.12
Total Debt/Equity
0.05
0.28
0.17
0.29
0.26
Interest Cover
11.42
-0.94
0.62
10.03
2.53

News Update:


  • Makers Laboratories - Quarterly Results
    8th Aug 2025, 11:58 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.